| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novelstem International Corp. (NSTM) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 4 sells. NSTM is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2013 | Baker Street Capital Management, LLC | 10% Owner | Sell | 12,300 | $1.53 | $18,863.28 | -0.4% | |
| Mar 17, 2011 | Gomez Scott | Chief Accounting Officer | Sell | 26,714 | $1.62 | $43,145.78 | -100% | |
| Mar 7, 2011 | Rubenstein Mitchell | Chairman And CEO | Sell | 323,485 | $1.63 | $527,054.11 | -48.5% | |
| Feb 18, 2011 | Baker Street Capital Management, LLC | 10% Owner | Sell | 1,714,679 | $2.05 | $3,515,091.95 | -33.2% |